PTGX
Protagonist TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
PTGX vs peer average
40/100
PTGX vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 1 · D 4 · F 2
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
IMVT is the first available peer comparator.
Late-stage biotech with valuation heavily driven by a narrow set of immunology catalysts and balance-sheet runway, making it a useful comparator for milestone concentration and binary-event sensitivity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PTGX
Protagonist Therapeutics
IMVT
Immunovant
Grade
D
D
Momentum
79
71
Value
56
41
Sentiment
27
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs IMVT
PTGX / IMVT
Grade Position
Below peers
PTGX vs. peer average (D vs. C)
40/100
Momentum
79
PTGXValue
56
PTGXSentiment
27
IMVTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PTGX
IMVT is the first peer returned for this comparison set.